Sweden
· Delayed Price · Currency is SEK Xspray Pharma AB Statistics
Total Valuation
STO:XSPRAY has a market cap or net worth of SEK 1.16 billion. The enterprise value is 1.08 billion.
| Market Cap | 1.16B |
| Enterprise Value | 1.08B |
Important Dates
The last earnings date was Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XSPRAY has 37.14 million shares outstanding. The number of shares has increased by 24.60% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 37.14M |
| Shares Change (YoY) | +24.60% |
| Shares Change (QoQ) | +2.95% |
| Owned by Insiders (%) | 6.23% |
| Owned by Institutions (%) | 35.50% |
| Float | 25.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.87 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.80 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.78 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.61 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.57 |
| Interest Coverage | -145.74 |
Financial Efficiency
Return on equity (ROE) is -43.38% and return on invested capital (ROIC) is -23.72%.
| Return on Equity (ROE) | -43.38% |
| Return on Assets (ROA) | -22.50% |
| Return on Invested Capital (ROIC) | -23.72% |
| Return on Capital Employed (ROCE) | -43.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -11.42M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.22% in the last 52 weeks. The beta is 0.77, so STO:XSPRAY's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -22.22% |
| 50-Day Moving Average | 36.27 |
| 200-Day Moving Average | 52.67 |
| Relative Strength Index (RSI) | 42.09 |
| Average Volume (20 Days) | 18,590 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -281.14M |
| Pretax Income | -285.67M |
| Net Income | -285.52M |
| EBITDA | -272.59M |
| EBIT | -281.14M |
| Earnings Per Share (EPS) | -8.62 |
Balance Sheet
The company has 208.24 million in cash and 128.22 million in debt, giving a net cash position of 80.02 million or 2.15 per share.
| Cash & Cash Equivalents | 208.24M |
| Total Debt | 128.22M |
| Net Cash | 80.02M |
| Net Cash Per Share | 2.15 |
| Equity (Book Value) | 623.10M |
| Book Value Per Share | 16.78 |
| Working Capital | 88.93M |
Cash Flow
In the last 12 months, operating cash flow was -222.37 million and capital expenditures -4.38 million, giving a free cash flow of -226.75 million.
| Operating Cash Flow | -222.37M |
| Capital Expenditures | -4.38M |
| Free Cash Flow | -226.75M |
| FCF Per Share | -6.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:XSPRAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.60% |
| Shareholder Yield | -24.60% |
| Earnings Yield | -24.52% |
| FCF Yield | -19.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |